SEC Comment Letter for Acco Group Holdings (ACCL) — Dec 31, 2024
Acco Group Holdings Ltd
Date: Dec. 31, 2024 · CIK: 0002038378 · Accession: 0000000000-24-014347
AI Filing Summary & Sentiment
Show Raw Text
December 31, 2024
Cheung Po, LUI
Chief Executive Officer
Acco Group Holdings Ltd
Unit 2406, 24/F
Low Block, Grand Millennium Plaza
181 Queen’s Road Central, Hong Kong
Re:Acco Group Holdings Ltd
Draft Registration Statement on Form F-1
Submitted December 5, 2024
CIK No. 0002038378
Dear Cheung Po, LUI:
We have reviewed your draft registration statement and have the following
comment(s).
Please respond to this letter by providing the requested information and either
submitting an amended draft registration statement or publicly filing your registration
statement on EDGAR. If you do not believe a comment applies to your facts and
circumstances or do not believe an amendment is appropriate, please tell us why in your
response.
After reviewing the information you provide in response to this letter and your
amended draft registration statement or filed registration statement, we may have additional
comments.
Draft Registration Statement on Form F-1
Cover Page
Clearly disclose how you will refer to the holding company, subsidiaries, and other
entities when providing the disclosure throughout the document so that it is clear to
investors which entity the disclosure is referencing and which subsidiaries or entities
are conducting the business operations. Refrain from using terms such as “we” or
“our” when describing activities or functions of a subsidiary or other entity. For
example, disclose, if true, that your subsidiaries and/or other entities conduct
operations in the PRC, that the other entity is consolidated for accounting purposes
but is not an entity in which you own equity, and that the holding company does not 1.
December 31, 2024
Page 2
conduct operations. Disclose clearly the entity (including the domicile) in which
investors are purchasing an interest.
2.Provide a description of how cash is transferred through your organization and
disclose your intentions to distribute earnings or settle amounts owed under applicable
agreements. State whether any transfers, dividends, or distributions have been made to
date between the holding company, its subsidiaries, and consolidated entities, or to
investors, and quantify the amounts where applicable.
3.We note your disclosure that Star Blessings Limited will control “more than a
majority” of the voting power of your outstanding ordinary shares. If true, please
revise the cover page to disclose that the company will be a controlled company post-
offering, identify the controlling stockholder(s) and clearly disclose such
stockholders’ total voting power post-offering.
Prospectus Summary, page 1
4.Please revise the summary to present an objective description of the challenges and/or
weaknesses of your business and operations. As an example only, you highlight your
competitive advantages and growth strategy without equally prominent disclosure
regarding your challenges and/or weaknesses.
Prospectus Summary
Transfers of Cash to and from Our Subsidiaries, page 5
5.In this section and elsewhere you state you and your Operating Subsidiaries have not
distributed any earnings, nor do any plan to distribute earnings in the foreseeable
future. However, the statements of changes in stockholders' equity and cash flows
report dividends paid. Please reconcile or clarify.
Risk Factors Summary
Risks Relating to Jurisdictions Where We Operate, page 7
6.In your summary of risk factors, disclose the risks that your corporate structure and
being based in or having the majority of the company’s operations in the PRC poses
to investors. In particular, describe the significant regulatory, liquidity, and
enforcement risks with cross-references to the more detailed discussion of these risks
in the prospectus. For example, specifically discuss risks arising from the legal system
in the PRC, including risks and uncertainties regarding the enforcement of laws and
that rules and regulations in the PRC can change quickly with little advance notice;
and the risk that the PRC government may intervene or influence your operations at
any time, or may exert more control over offerings conducted overseas and/or foreign
investment in PRC-based issuers, which could result in a material change in your
operations and/or the value of the securities you are registering for sale. Acknowledge
any risks that any actions by the PRC government to exert more oversight and control
over offerings that are conducted overseas and/or foreign investment in PRC-based
issuers could significantly limit or completely hinder your ability to offer or continue
to offer securities to investors and cause the value of such securities to significantly
decline or be worthless.
December 31, 2024
Page 3
Risk Factors
Risks Relating to Our Business and Operations, page 19
7.We note your disclosures on pages 71 and 72 that you currently use generative
artificial intelligence in your business and one of your growth strategies is to “deploy
AI-powered tools to automate the compilation of data, generation of financial
statements and preparation of corporate and registration documentations.” Please
clarify whether you currently and/or in the future intend to utilize third-party artificial
intelligence products or internally developed artificial intelligence processes and
state whether you intend to utilize open-source technology or license the use of such
technology. To the extent you intend to license existing or future technologies or plan
to utilize proprietary and/or open-source technology, please add relevant risk
disclosure to address any related risks.
Use of Proceeds, page 51
8.We note your disclosure that you plan to use the proceeds of the offering to pursue
"selective strategic investments, relationships, and acquisition opportunities" and to
incorporate “generative AI features into our business modules through procurement
from or cooperation with third-party information technologies vendors.” If the
proceeds (i) are being used directly or indirectly to acquire assets, other than in the
ordinary course of business, please briefly describe the assets and their costs or (ii)
may or will be used to finance acquisitions of other businesses, give a brief
description of such businesses and information on the status of the acquisitions. Refer
to Item 3.C of Form 20-F.
Dilution, page 56
9.Please tell us whether pro forma net tangible book value is presented on the same
basis as pro forma as adjusted basis for capitalization on page 55. If so, revise to use
the term “pro forma” and “pro forma as adjusted” consistently between the two
disclosures.
Management's Discussion and Analysis of Financial Condition and Results of Operations
Results of Operations
Revenue, page 59
10.Please separately quantify the impact of the increases in the number of clients and the
service fees on your corporate secretarial services revenue during the year ended June
30, 2024. Refer to Item 5.A.1 of Form 20-F.
Gross Profit, page 60
11.While you primarily attribute the 16.2% increase in cost of revenue to the increase in
the business registration fee paid to the Hong Kong SAR Government, you do not
mention this cost increase as an offsetting factor for the overall increase in gross profit
and gross profit margin. Please advise or revise.
Related Party Transactions, page 91
We note the amount due from Mr. Yuen Yuk, HAU in this section. Section 402 of the 12.
December 31, 2024
Page 4
Sarbanes-Oxley Act of 2002 prohibits public companies from extending or
maintaining credit in the form of personal loans to or for any director or executive
officer. To the extent necessary, disclose the action that will be taken to ensure any
applicable arrangements will be extinguished prior to the completion of the initial
public offering or tell us why this provision does not apply to any of the advances
disclosed in this section. Further, please revise your definition of related party
transactions to comply with Item 7.B of Form 20-F.
Underwriting
Discounts and Expenses, page 115
13.Please revise this table to add columns reflecting discounts and expenses with and
without the exercise of the over-allotment option.
Note 2 - Summary of Significant Accounting Policies, page F-8
14.Please disclose your accounting policy for cost of revenues.
Notes to the Consolidated Financial Statements
Note 1 - Organization and Principal Activities
Group Reorganization, page F-8
15.Please tell us and clearly disclose whether common control existed between you,
Accolade Consultants Limited, Accolade Corporate Services Limited and Accolade IP
(SG) Pte. Ltd. as of July 1, 2022 and the basis for the common control (e.g., the
entity/person holding the common control). If all 4 entities were not under common
control as of July 1, 2022, explain to us and disclose as appropriate the basis for
combining the financial statements of these entities.
16.Please tell and disclose the source of the cash considerations for the acquisitions of
Accolade Consultants Limited, Accolade Corporate Services Limited and Accolade IP
(SG) Pte. Ltd. mentioned here, the amount of the cash considerations and how you
accounted for the cash payments.
Revenue Recognition, page F-12
17.Please clarify whether the transaction price is outlined in the accounting services
contract for each performance obligation or disclose how you allocate the transaction
price to each performance obligation.
18.Your disclosures of Suppliers Concentration on page F-23 and Related Party
Transactions on page F-26 appear to indicate that some of your revenue generating
services are provided by third parties. In those instances when another party is
involved in providing services to a customer, please disclose how you determined that
you are the principal, rather than an agent, for providing promised services. Refer to
ASC 606-10-55-36 through 55-40.
19.Please disaggregate revenues according to the timing of transfer of services (e.g.,
revenue from services transferred to customers at a point in time vs. services
transferred to customers over time). Refer to ASC 606-10-55-91.
December 31, 2024
Page 5
Note 8 - Accrued Liabilities and Other Payables, page F-19
20.Please provide a description of items included under “other payables.” Separately
quantify these items to the extent they exceed 5% of total current liabilities. Refer to
Item 5-02(20) of Regulation S-X.
Part II - Information Not Required in the Prospectus
Item 8. Exhibits and Financial Statement Schedule, page II-2
21.We note that the prospectus includes industry data based on a report from Marksman
Services Group Limited that was commissioned by you. Please file the consent of
such third party pursuant to Rule 436 of the Securities Act as an exhibit to your
registration statement.
22.Please revise your exhibit index to reference and file the opinion of your PRC
counsel.
Please contact Keira Nakada at 202-551-3659 or Doug Jones at 202-551-3309 if you
have questions regarding comments on the financial statements and related matters. Please
contact Jenny O'Shanick at 202-551-8005 or Evan Ewing at 202-551-5920 with any other
questions.
Sincerely,
Division of Corporation Finance
Office of Trade & Services